https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
These results suggest that anticarin β is a promising candidate inhibitor for malignant glioma.Glioblastoma (GBM) is a common and refractory subtype of high-grade glioma with a poor prognosis. The epithelial-mesenchymal transition (EMT) is an important cause of enhanced glioblastoma invasiveness and tumor recurrence. Our previous study found that retinoic acid receptor-related orphan receptor A (RORA) is a nuclear receptor and plays an important role in inhibiting proliferation and tumorigenesis of glioma. We further c
Aimer
Commentaire
Partagez
